Search for: "Astrazeneca"
Results 261 - 280
of 1,244
Sort by Relevance
|
Sort by Date
29 Jun 2018, 12:21 pm
(“Impax”), AstraZeneca AB, and AstraZeneca UKLimited (together, “AstraZeneca”), and entering an injunctionagainst Lannett pursuant to 35 U.S.C. [read post]
2 May 2018, 2:15 pm
CRISPR appointed Ho, who previously worked at AstraZeneca and Merck, as its head of R&D in August. [read post]
3 Apr 2018, 7:50 am
The Washington Post deserves credit for its investigative dissection of AstraZeneca and its “blockbuster” product, Seroquel (generic name quetiapine). [read post]
2 Apr 2018, 8:37 am
The event will be held at on 9 April 2018 at Academy House, Hills Road, Cambridge CB2 8PA and will be an excellent opportunity to hear from two fascinating speakers, Rebekah Martin, Deputy General Counsel at AstraZeneca, who will talk about the challenges faced by a large multinational company when preparing for Brexit, and Christine Martin, an Investment Manager at Cambridge Enterprise. [read post]
15 Feb 2018, 2:21 pm
Esomeprazole is sold over the counter by AstraZeneca as Nexium. [read post]
12 Feb 2018, 12:05 pm
Continuing, this Kombiglyze / Onglyza MDL Transfer Order sets forth the JPML's take on that contention by AstraZeneca, Bristol-Myers Squibb, and McKesson: Defendants concede that most cases involve allegations of heart failure, which is squarely in line with the results of the SAVOR study and the subsequent label change for Onglyza and Kombiglyze XR in April 2016. [read post]
17 Jan 2018, 9:04 am
La doctrine de la promesse a été rejetée par la Cour suprême du Canada en juin 2017 dans l’affaire AstraZeneca Canada Inc. c. [read post]
10 Jan 2018, 6:36 pm
” AstraZeneca AB v.Apotex Corp., 782 F.3d 1324, 1334 (Fed. [read post]
13 Dec 2017, 9:36 am
AstraZeneca Insurance Co. [read post]
13 Dec 2017, 9:36 am
AstraZeneca Insurance Co. [read post]
1 Dec 2017, 11:35 am
.), AstraZeneca (U.S), Roche (Switzerland) and Aimmune Therapeutics (U.S.). [read post]
11 Nov 2017, 11:00 am
See AstraZeneca LP v. [read post]
25 Oct 2017, 12:59 am
Functionality and Scope of Protection by edited by Chris Carani€ 199 3D Printing, Intellectual Property and Innovation: Insights from Law and Technology by Rosa Maria Ballardini, Marcus Norrgård, Jouni Partanen€ 128 The Unitary Patent and the Unified Patent Court by Pieter Callens & Sam Granata€ 150 … [read post]
19 Oct 2017, 6:08 am
The lawsuit, filed in the US District Court for the District of Columbia [official website], accuses defendants AstraZeneca, GE Healthcare, Johnson & Johnson, Pfizer and Roche of violating several provisions of the federal Anti-Terrorism Act... [read post]
18 Oct 2017, 7:32 am
In Canada there has been has been a sea change in this area following the recent Supreme Court decision in AstraZeneca abandoned the requirement that the claims satisfy the “promise of the patent” (although intentionally over claiming may still be a basis for invalidity). [read post]
10 Oct 2017, 4:12 pm
Astrazeneca Pharmaceutical LP held a leave of absence or a leave extension can constitute a reasonable accommodation under the ADA “in some circumstances”, although in that case ultimately concluded the plaintiff could not show her request for twelve additional months of leave was facially reasonable. [read post]
10 Oct 2017, 4:12 pm
Astrazeneca Pharmaceutical LP held a leave of absence or a leave extension can constitute a reasonable accommodation under the ADA “in some circumstances”, although in that case ultimately concluded the plaintiff could not show her request for twelve additional months of leave was facially reasonable. [read post]
26 Sep 2017, 5:20 am
Functionality and Scope of Protection by edited by Chris Carani€ 199 The post Spain: Accord and Sandoz vs Astrazeneca, Supreme Court of Spain, First Civil Law Chamber, 334/2016, 20 May 2016 appeared first on Kluwer Patent Blog. [read post]
7 Sep 2017, 9:59 pm
AstraZeneca AB affirming the patentability of all challenged claims. [read post]
16 Aug 2017, 11:08 am
But the JPML was not convinced by their arguments, as seen from this excerpt from the Transfer Order: And, although it is true that AstraZeneca is sued in far more actions than Takeda, a significant number of actions are “mixed use” cases in which the plaintiffs allege use of more than one PPI, and sue Takeda and one or more other PPI manufacturers, including AstraZeneca. [read post]
